StockWatch
·
Pharmaceuticals
AGM/EGM16 Jul 2026, 06:40 pm

Auro Labs files FY26 Annual Report & 37th AGM Notice

AI Summary

Auro Laboratories Ltd has submitted its Annual Report for the Financial Year 2025-2026, in compliance with Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The submission includes the Notice for the 37th Annual General Meeting (AGM), which is scheduled to be held on Tuesday, August 11, 2026, at 11:30 AM (IST) through Video Conferencing/Other Audio-Visual Means. The key business items for the AGM include the adoption of the audited financial statements for the year ended March 31, 2026, and the re-appointment of Mr. Kiran Kulkarni as a director who retires by rotation. The Annual Report and Notice are also accessible on the company's website.

Key Highlights

  • Auro Labs submitted its Annual Report for FY 2025-2026.
  • The 37th Annual General Meeting is scheduled for August 11, 2026.
  • AGM agenda includes adopting FY26 audited financial statements.
  • Re-appointment of director Mr. Kiran Kulkarni is also on agenda.